146
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer

, , , , , & show all
Pages 3625-3640 | Published online: 26 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yasemin Kilciler, Asuman Deveci Ozkan & Zeynep Betts. (2022) Protective effect of Eisenia foetida coelomic fluid against oxidative damage in human endothelial cells. Toxicological & Environmental Chemistry 104:2, pages 307-320.
Read now
Yang Yang, Guangyuan Zhang, Chuangang Li, Sihan Wang, Manning Zhu, Jinan Wang, Hangtian Yue, Xiaodong Ma, Yuhong Zhen & Xiaohong Shu. (2019) Metabolic profile and structure–activity relationship of resveratrol and its analogs in human bladder cancer cells. Cancer Management and Research 11, pages 4631-4642.
Read now

Articles from other publishers (12)

Sasireka Rajendran, Sai Nandhini Ravi, Vaishnavi M. Nair, R. Pooja Sree, Azhagu Saravana Babu Packirisamy & Jeyanthi Palanivelu. (2024) Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy. Topics in Catalysis 67:1-4, pages 203-217.
Crossref
Ye Shang, Suyi Liu, Chunxiao Liang, Kunze Du, Shujing Chen, Jin Li, Hua Jin & Yanxu Chang. (2022) An Integrated Strategy of Chemical Fingerprint and Network Pharmacology for the Discovery of Efficacy-Related Q-Markers of Pheretima. International Journal of Analytical Chemistry 2022, pages 1-12.
Crossref
Chenfan Kong, Shaohua Zhang, Qifang Lei & Song Wu. (2022) State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer. Biosensors 12:10, pages 796.
Crossref
Asuman Deveci Ozkan, Gamze Guney Eskiler, Mehmet Sarihan, Nur Kazan, Ozlem Aksoy, Burcu Yuksel & Zeynep Betts. (2022) Anticancer Properties of Eisenia Foetida Proteins in Prostate Cancer Cells In Vitro. International Journal of Peptide Research and Therapeutics 28:4.
Crossref
Sin-Woo Seong, Youngjae Shin, In Ho Chang & Jung Hoon Kim. (2022) The Present and Future of Intravesical Therapy in Bladder Cancer. The Korean Journal of Urological Oncology 20:2, pages 82-91.
Crossref
Javad Sharifi-Rad, Cristina Quispe, Jayanta Kumar Patra, Yengkhom Disco Singh, Manasa Kumar Panda, Gitishree Das, Charles Oluwaseun Adetunji, Olugbenga Samuel Michael, Oksana Sytar, Letizia Polito, Jelena Živković, Natália Cruz-Martins, Marta Klimek-Szczykutowicz, Halina Ekiert, Muhammad Iqbal Choudhary, Seyed Abdulmajid Ayatollahi, Bekzat Tynybekov, Farzad Kobarfard, Ana Covilca Muntean, Ioana Grozea, Sevgi Durna Daştan, Monica Butnariu, Agnieszka Szopa & Daniela Calina. (2021) Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy. Oxidative Medicine and Cellular Longevity 2021, pages 1-24.
Crossref
Mahmood Barani, Seyedeh Maryam Hosseinikhah, Abbas Rahdar, Leila Farhoudi, Rabia Arshad, Magali Cucchiarini & Sadanand Pandey. (2021) Nanotechnology in Bladder Cancer: Diagnosis and Treatment. Cancers 13:9, pages 2214.
Crossref
F. Pisano, J. M. Gaya, O. Rodriguez Faba, A. Breda & J. Palou. 2021. Urologic Surgery in the Digital Era. Urologic Surgery in the Digital Era 39 51 .
Kun Yu, Meiping Liu, Hong Dai & Xiao Huang. (2020) Targeted drug delivery systems for bladder cancer therapy. Journal of Drug Delivery Science and Technology 56, pages 101535.
Crossref
Oluwadamilola M. Kolawole, Wing Man Lau & Vitaliy V. Khutoryanskiy. (2019) Chitosan/β-glycerophosphate in situ gelling mucoadhesive systems for intravesical delivery of mitomycin-C. International Journal of Pharmaceutics: X 1, pages 100007.
Crossref
Francesca Pisano, H. Vila Reyes, A. Breda & J. Palou. (2019) Updates on intravesical therapy. Current Opinion in Urology 29:6, pages 649-655.
Crossref
Z. Ma, P. Qian, R. Shen, B. Hu, X. He, F. Gao, B. Shen, N. Zhang, Y. Shan, X. Shen, T. Gao & L. Jin. (2019) Pharmacological Signatures of the Exenatide Nanoparticles Against Hepatic Ischemia/Reperfusion-induced Pancreatic Injury. Transplantation Proceedings 51:3, pages 960-965.
Crossref